Net shares · 365d
-6.6K
0 buy · 6.6K sell
Net value · 365d
-$200.4K
$0 in · $200.4K out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
3
0 buy · 6.6K sell
Trading track record · all companies
Not enough open-market trades to chart a track record yet.
Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.
Transactions · 365d
-
SLNO Other·D
Sr. VP of Clinical Development
—
135.7K sh · 3 lots
Own -100%
-
SLNO Other·D
Sr. VP of Clinical Development
—
39.8K sh
Own -100%
-
SLNO Sell·S
Sr. VP of Clinical Development
$200.4K
6.6K sh · $30.44 avg · 3 lots
Own -14%
-
SLNO Grant·A
Sr. VP of Clinical Development
$0
11.9K sh
Own New
-
SLNO Grant·A
Sr. VP of Clinical Development
$0
10.4K sh
Own +29%
-
SLNO Other·F
Sr. VP of Clinical Development
$40.6K
812 sh · $49.95
Own -2%
| Date▾ | Ticker | Type | Shares | Value |
|---|---|---|---|---|
| May 18, 2026 | SLNO | Other D | 135.7K · 3 lots | — |
| May 18, 2026 | SLNO | Other D | 39.8K | — |
| Mar 27, 2026 | SLNO | Sell S | 6.6K · 3 lots | $200.4K |
| Jan 21, 2026 | SLNO | Grant A | 11.9K | $0 |
| Jan 21, 2026 | SLNO | Grant A | 10.4K | $0 |
| Dec 15, 2025 | SLNO | Other F | 812 | $40.6K |
Buy Sell Non-market (grant · exercise · gift)
About Huang Michael F.
This profile aggregates every SEC Form 4 insider transaction reported by Huang Michael F. across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.